PB2065: IMPORTANCE OF PET AS A PROGNOSTIC MARKER IN TREATMENT STRATEGY CHOICE IN PATIENTS WITH HODGKIN LYMPHOMA

• O. Novosad,
• I. Pastushenko,
• T. Kadnikova,
• I. Tytorenko,
• A. Martynchyk,
• O. Gorbach,
• A. Ashyhmin,
• Y. Kmetyuk,
• O. Karpova,
• L. Mykhalska,
• O. Kindrakevych,
• M. Novikov,
• O. Oliinichenko,
• I. Kriachok

Affiliations

O. Novosad

1 Oncohematology

I. Pastushenko

1 Oncohematology

T. Kadnikova

1 Oncohematology

I. Tytorenko

1 Oncohematology

A. Martynchyk

1 Oncohematology

O. Gorbach

1 Oncohematology

A. Ashyhmin

2 Radiology, National Cancer Institute

Y. Kmetyuk

3 Radiology

O. Karpova

3 Radiology

L. Mykhalska

4 Oncohematology, Clinical Hospital “Feofaniya”

O. Kindrakevych

4 Oncohematology, Clinical Hospital “Feofaniya”

M. Novikov

5 Radiology, Oncology Hospital “LISOD”

O. Oliinichenko

6 Radiology, Center of Nuclear Medicine KMCOC, Kiev, Ukraine

I. Kriachok

1 Oncohematology